{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:20:11Z","timestamp":1761513611697},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1097\/md.0000000000000476","type":"journal-article","created":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T18:12:32Z","timestamp":1427479952000},"page":"e476","source":"Crossref","is-referenced-by-count":13,"title":["Severe Cholestatic Hepatitis due to Temozolomide"],"prefix":"10.1097","volume":"94","author":[{"given":"Antonio","family":"Grieco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Tafuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Biolato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Diletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Di Napoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Maria","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Miele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210226","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-1-20210226","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"R3-1-20210226","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ijrobp.2009.05.031","article-title":"Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide","volume":"77","author":"Weiler","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-1-20210226","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1748-717X-6-141","article-title":"Toxicity after radiochemotherapy for glioblastoma using temozolomide-a retrospective evaluation","volume":"6","author":"Niewald","year":"2011","journal-title":"Radiat Oncol"},{"key":"R5-1-20210226","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/CAD.0b013e328356f5b0","article-title":"Temozolomide-related idiosyncratic and other uncommon toxicities: a systematic review","volume":"23","author":"Dixit","year":"2012","journal-title":"Anticancer Drugs"},{"key":"R6-1-20210226","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1212\/01.wnl.0000259430.48835.b5","article-title":"Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note","volume":"68","author":"Chheda","year":"2007","journal-title":"Neurology"},{"key":"R7-1-20210226","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/neuonc\/nos056","article-title":"Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system","volume":"14","author":"Sarganas","year":"2012","journal-title":"Neuro Oncol"},{"key":"R8-1-20210226","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11060-010-0354-y","article-title":"Hepatic encephalopathy after treatment with temozolomide","volume":"103","author":"Goldbecker","year":"2011","journal-title":"J Neurooncol"},{"key":"R9-1-20210226","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.3748\/wjg.14.6774","article-title":"Practical guidelines for diagnosis and early management of drug-induced liver injury","volume":"14","author":"Tajiri","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R10-1-20210226","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3747\/co.19.1151","article-title":"Extended adjuvant temozolomide with cis-retinoic acid for adult glioblastoma","volume":"19","author":"Pitz","year":"2012","journal-title":"Curr Oncol"},{"key":"R11-1-20210226","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1472-6882-14-115","article-title":"Liver toxicity during temozolomide chemotherapy caused by Chinese herbs","volume":"14","author":"Melchardt","year":"2014","journal-title":"BMC Complement Altern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:40:46Z","timestamp":1620960046000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201503040-00001"}},"subtitle":["An Adverse Drug Effect to Keep in Mind. Case Report and Review of Literature"],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000476","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}